Epidermal growth factor receptor (EGFR) inhibitor associated skin eruption

Seiverling, E.V.; Fernanadez, E.M.; Adams, D.

Journal of Drugs in Dermatology Jdd 5(4): 368-369

2006


ISSN/ISBN: 1545-9616
PMID: 16673807
Document Number: 8872
EGFR Inhibitors are used to treat Non-Small-Cell Lung Cancer (NSCLC) and colorectal cancer (CRC). A common side effect of EGFR Inhibitors is a follicular/pustular skin eruption. We report a case of gefitinib (Iressa) associated skin eruption. The treatment regimen consisted of triamcinolone 0.1% cream twice daily, clindamycin 1% lotion twice daily and sodium sulfacetamide lotion twice daily. The clinical presentation, etiology, and management options of EGFR Inhibitor associated skin eruptions are discussed.

Document emailed within 1 workday
Secure & encrypted payments

Epidermal growth factor receptor (EGFR) inhibitor associated skin eruption